Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early lyme disease

Journal of Infectious Diseases

Volumn 180, Issue 3, 1999, Pages 720-725

  Wormser, Gary P ^a,b   Liveris, Dionysios ^a   Nowakowski, John ^a   Nadelman, Robert B ^a   Cavaliere, L Frank ^a   McKenna, Donna ^a   Holmgren, Diane ^a   Schwartz, Ira ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL VIRULENCE; BORRELIA BURGDORFERI; CLINICAL FEATURE; ERYTHEMA CHRONICUM MIGRANS; GENETIC VARIABILITY; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKIN BIOPSY;

ADULT; BIOPSY; BORRELIA BURGDORFERI GROUP; ERYTHEMA CHRONICUM MIGRANS; HUMANS; LYME DISEASE; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SKIN; VARIATION (GENETICS);

EID: 0032875501     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314922     Document Type: Article

References (35)

1. 1. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998;352:557-65.
2. 2. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987;107:725-31.
3. 3. Krause PJ, Telford SR III, Spielman A, et al. Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illness. JAMA 1996;275:1657-60.
4. 4. Nadelman RB, Horowitz HW, Hsieh TC, et al. Simultaneous human ehrlichiosis and Lyme borreliosis. N Engl J Med 1997;337:27-30.
5. 5. Kim N, Rosenbaum GS, Cunha A. Relative bradycardia and lymphopenia in patients with babesiosis. Clin Infect Dis 1998;26:1218-9.
6. 6. Baranton G, Postic D, Saint Girons I, et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992;42:378-83.
7. 7. Kawabata H, Masuzawa T, Yanagihara Y. Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovatus in Japan. Microbiol Immunol 1993;37:843-8.
8. 8. Le Fleche A, Postic D, Girardet K, Peter O, Baranton G. Characterization of Borrelia Iusitaniae sp. nov. by I6S ribosomal DNA sequence analysis. Int J Syst Bacteriol 1997;47:921-5.
9. 9. Marconi RT, Liveris D, Schwartz I. Identification of novel insertion elements, restriction fragment length polymorphism patterns, and discontinuous 23S rRNA in Lyme disease spirochetes: phylogenetic analyses of rRNA genes and their intergenic spacers in Borrelia japonica sp. nov. and genomic group 21038 (Borrelia andersonii sp. nov.) isolates. J Clin Microbiol 1995;33:2427-34.
10. 10. Welsh J, Pretzman C, Postic D, Saint Girons I, Baranton G, McClelland M. Genomic fingerprinting by arbitrarily primed polymerase chain reaction resolves Borrelia burgdorferi into three distinct phyletic groups. Int J Syst Bacteriol 1992;42:370-7.
11. 11. Postic D, Assous MV, Grimont PA, Baranton G. Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf (5S)-rrl (23S) intergenic spacer amplicons. Int J Syst Bacteriol 1994;44:743-52.
12. 12. Strle F, Picken RN, Cheng Y, et al. Clinical findings for patients with Lyme borreliosis caused by Borrelia burgdorferi sensu lato with genotypic and phenotypic similarities to strain 25015. Clin Infect Dis 1997;25:273-80.
13. 13. Postic D, Ras NM, Lane RS, Henderson M, Baranton G. Expanded diversity among Californian Borrelia isolates and description of Borrelia bissettii sp. nov. (formerly Borrelia group DN127). J Clin Microbiol 1998;36: 3497-504.
14. 14. Balmelli T, Piffaretti JC. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res Microbiol 1995;146:329-40.
15. 15. van Dam AP, Kuiper H, Vos K, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993;17:708-17.
16. 16. Liveris D, Gazumyan A, Schwartz I. Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 1995;33:589-95.
17. 17. Mathiesen DA, Oliver JH Jr, Kolbert CP, et al. Genetic heterogeneity of Borrelia burgdorferi in the United States. J Infect Dis 1997;175:98-107.
18. 18. Foretz M, Postic D, Baranton G. Phylogenetic analysis of Borrelia burgdorferi sensu stricto by arbitrarily primed PCR and pulsed-field gel electrophoresis. Int J Syst Bacteriol 1997;47:11-8.
19. 19. Liveris D, Varde S, Iyer R, et al. Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol 1999;37:565-9.
20. 20. Luft BJ, Dattwyler RJ, Johnson RC, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized controlled trial. Ann Intern Med 1996;124:785-91.
21. 21. Schwartz I, Wormser GP, Schwartz JJ, et al. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol 1992;30:3082-8.
22. 22. Nadelman RB, Pavia CS, Magnarelli LA, Wormser GP. Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease. Am J Med 1990;88:21-6.
23. 23. Wormser GP, Nowakowski J, Nadelman RB, Bittker S, Cooper D, Pavia C. Improving the yield of blood cultures for patients with early Lyme disease. J Clin Microbiol 1998;36:296-8.
24. 24. Nowakowski J, Nadelman R, Bittker S, et al. Serum versus plasma as a culture source for Borrelia burgdorferi in early Lyme disease [abstract 25-D.D3]. In: Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC; American Society for Microbiology, 1998.
25. 25. Wormser GP, Forseter G, Cooper D, et al. Use of a novel technique of cutaneous lavage for diagnosis of Lyme disease associated with erythema migrans. JAMA 1992;268:1311-3.
26. 26. Jobe DA, Callister SM, Schell RF. Recovery of Borrelia burgdorferi by filtration. J Clin Microbiol 1993;31:1896-8.
27. 27. Schwartz I, Varde S, Nadelman RB, Wormser GP, Fish D. Inhibition of efficient polymerase chain reaction amplification of Borrelia burgdorferi DNA in blood-fed ticks. Am J Trop Med Hyg 1997;56:339-42.
28. 28. Liveris D, Wormser GP, Nowakowski J, et al. Molecular typing of Borrelia burgdorferi from Lyme disease patients by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 1996;34:1306-9.
29. 29. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25: 4876-82.
30. 30. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 1996;34:1-9.
31. 31. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995;44:590-1.
32. 32. Norusis MJ, ed. SPSS, release 4.0. Chicago: Statistical Package for the Social Sciences, 1990.
33. 33. Gustafson T. True Epistat reference manual. Version 5.1, Richardson, TX: Epistat Services, 1994.
34. 34. Wormser GP, Nowakowski J, Nadelman RB, et al. Efficacy of an OspA vaccine preparation for prevention of Lyme disease in New York State. Infection 1998;26:208-12.
35. 35. Gazumyan A, Schwartz JJ, Liveris D, Schwartz I. Sequence analysis of the ribosomal RNA operon of the Lyme disease spirochete, Borrelia burgdorferi. Gene 1994;146:57-65.